PAIN: A Project Assessing the Impact of a Novel Cannabinoid Product

Summary

This study is a clinical trial of a high-cannabidiol (CBD) sublingual product compared to placebo for 9 weeks in patients with chronic pain conditions. The study will assess the impact of CBD on chronic pain symptoms, conventional medication use, clinical state, quality of life, cognition, and biomarkers.

Timeline

Start

2024-06-27

Primary completion

2026-09

Completion

2026-09

Drugs

Indications